Home » Newsletters » BioWorld Science

BioWorld Science

March 12, 2010

View Archived Issues

Hedgehog pathway antagonist GDC-0449 shows clinical promise in metastatic basal cell carcinoma

Topical antifungal agent NB-002 under clinical development for distal subungual onychomycosis

Phase I trial of deferoxamine in acute cerebral hemorrhage currently recruiting participants

Tibotec discloses NS5B inhibitors for treatment of HCV infection

Casein kinase I inhibitors identified by sanofi-aventis

Argenta Discovery and AstraZeneca claim M3 receptor antagonists for COPD

Astex and Novartis claim the discovery of novel CDK4 inhibitors

Scottish scientists describe new cannabinoid CB1 receptor antagonists

Merck & Co.'s allergy immunotherapy tablet reduces grass pollen allergy symptoms in children

Phase III VIAject recombinant human insulin data presented

Biomoda and Obio collaborate to expand lung cancer screening program

NeoPharm files orphan drug application with FDA for IL13-PE for idiopathic pulmonary fibrosis

Sanofi-aventis acquires Chattem

BioInvent and Human Genome Sciences enter collaboration for monoclonal antibodies

BioAlliance reports preliminary phase I data on Lauriad for cancer pain

Advanced Life Sciences receives FDA guidance approval pathway for Restanza for CABP

Medivir outlicenses hepatitis B therapeutic MIV-210 to Daewoong

FDA accepts Dainippon Sumitomo's lurasidone NDA for schizophrenia for review

Generex receives positive feedback from independent clinicians on Oral-lyn

Evotec reports product development in treatment-resistant depression

Cangene, Baxter and FDA warn of risk of intravascular hemolysis with ITP therapeutic WinRho SDF

Allon Therapeutics completes phase I trial of neuroprotective agent davunetide

Access' Cobalamin oral insulin shows significant oral bioavailability in preclinical studies

BioSante reports clinical data on GVAX leukemia vaccine in chronic myeloid leukemia

ProFibrix reports preliminary phase II data on Fibrocaps

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...